| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Care | 65 | 2024 | 2712 | 6.430 |
Why?
|
| Intensive Care Units, Pediatric | 62 | 2022 | 1019 | 6.230 |
Why?
|
| Status Epilepticus | 33 | 2024 | 460 | 5.500 |
Why?
|
| Brain Injuries | 38 | 2022 | 2060 | 5.200 |
Why?
|
| Critical Illness | 44 | 2022 | 2744 | 3.370 |
Why?
|
| Intracranial Pressure | 17 | 2022 | 322 | 3.270 |
Why?
|
| Brain Death | 8 | 2023 | 360 | 3.090 |
Why?
|
| Pediatrics | 30 | 2024 | 3606 | 2.540 |
Why?
|
| Intracranial Hypertension | 17 | 2023 | 190 | 2.420 |
Why?
|
| Apnea | 6 | 2020 | 193 | 2.270 |
Why?
|
| Periodicals as Topic | 8 | 2024 | 1462 | 2.240 |
Why?
|
| Craniosynostoses | 13 | 2024 | 404 | 2.170 |
Why?
|
| Anticonvulsants | 25 | 2024 | 1921 | 2.110 |
Why?
|
| Shock, Septic | 15 | 2024 | 774 | 2.090 |
Why?
|
| Child | 203 | 2024 | 80564 | 2.050 |
Why?
|
| Midazolam | 8 | 2022 | 267 | 1.800 |
Why?
|
| Respiration, Artificial | 27 | 2021 | 2709 | 1.700 |
Why?
|
| Multiple Organ Failure | 10 | 2022 | 390 | 1.590 |
Why?
|
| Writing | 3 | 2024 | 199 | 1.580 |
Why?
|
| Diabetic Ketoacidosis | 7 | 2020 | 253 | 1.580 |
Why?
|
| Cerebrovascular Circulation | 18 | 2020 | 2674 | 1.570 |
Why?
|
| Sepsis | 18 | 2024 | 2606 | 1.510 |
Why?
|
| Hypothermia, Induced | 9 | 2019 | 752 | 1.500 |
Why?
|
| Coma | 11 | 2020 | 485 | 1.330 |
Why?
|
| Child, Preschool | 123 | 2024 | 42500 | 1.330 |
Why?
|
| Hypoglycemia | 8 | 2014 | 896 | 1.310 |
Why?
|
| Delirium | 7 | 2024 | 1707 | 1.260 |
Why?
|
| Hyperglycemia | 12 | 2014 | 1393 | 1.250 |
Why?
|
| Infant | 117 | 2024 | 36386 | 1.230 |
Why?
|
| Monitoring, Physiologic | 19 | 2021 | 1792 | 1.190 |
Why?
|
| Water-Electrolyte Imbalance | 2 | 2020 | 110 | 1.080 |
Why?
|
| Humans | 325 | 2024 | 765968 | 1.050 |
Why?
|
| Seizures | 17 | 2023 | 3000 | 1.050 |
Why?
|
| Glasgow Coma Scale | 14 | 2024 | 575 | 1.030 |
Why?
|
| Brain Diseases | 7 | 2022 | 1546 | 1.000 |
Why?
|
| Brain Edema | 6 | 2014 | 602 | 0.970 |
Why?
|
| Blood Glucose | 11 | 2014 | 6424 | 0.890 |
Why?
|
| Respiratory Insufficiency | 13 | 2022 | 1240 | 0.890 |
Why?
|
| Hypnotics and Sedatives | 4 | 2018 | 1191 | 0.870 |
Why?
|
| Heart Arrest | 7 | 2017 | 1516 | 0.850 |
Why?
|
| Hydrocortisone | 5 | 2015 | 1827 | 0.850 |
Why?
|
| Benzodiazepines | 10 | 2024 | 1136 | 0.850 |
Why?
|
| Pentobarbital | 3 | 2022 | 153 | 0.830 |
Why?
|
| Infant, Newborn | 60 | 2024 | 26346 | 0.810 |
Why?
|
| Diagnostic Techniques, Neurological | 2 | 2020 | 62 | 0.790 |
Why?
|
| Cholinergic Antagonists | 3 | 2021 | 165 | 0.780 |
Why?
|
| Neurology | 6 | 2023 | 785 | 0.780 |
Why?
|
| Extracorporeal Membrane Oxygenation | 7 | 2020 | 1480 | 0.770 |
Why?
|
| High-Frequency Ventilation | 5 | 2008 | 90 | 0.770 |
Why?
|
| Hypoxia, Brain | 3 | 2014 | 139 | 0.750 |
Why?
|
| Brain | 16 | 2022 | 27171 | 0.730 |
Why?
|
| Epinephrine | 2 | 2015 | 783 | 0.720 |
Why?
|
| Brain Concussion | 3 | 2019 | 1432 | 0.720 |
Why?
|
| Central Nervous System Diseases | 5 | 2020 | 518 | 0.710 |
Why?
|
| Cholinesterases | 1 | 2020 | 32 | 0.700 |
Why?
|
| Paralysis | 1 | 2022 | 248 | 0.700 |
Why?
|
| Unconsciousness | 2 | 2020 | 250 | 0.700 |
Why?
|
| Electroencephalography | 20 | 2024 | 6273 | 0.700 |
Why?
|
| Catastrophic Illness | 1 | 2020 | 60 | 0.690 |
Why?
|
| Adolescent | 92 | 2024 | 88835 | 0.680 |
Why?
|
| Cardiopulmonary Resuscitation | 4 | 2017 | 1002 | 0.680 |
Why?
|
| Clinical Protocols | 7 | 2022 | 1441 | 0.670 |
Why?
|
| Respiratory Syncytial Virus Infections | 5 | 2008 | 365 | 0.670 |
Why?
|
| Hospital Mortality | 14 | 2022 | 5343 | 0.670 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 4 | 2020 | 276 | 0.670 |
Why?
|
| Craniocerebral Trauma | 6 | 2006 | 494 | 0.640 |
Why?
|
| Malformations of Cortical Development | 1 | 2021 | 174 | 0.640 |
Why?
|
| Shock | 2 | 2015 | 316 | 0.630 |
Why?
|
| Anesthesia, General | 3 | 2017 | 1172 | 0.630 |
Why?
|
| Nervous System Diseases | 4 | 2022 | 1660 | 0.620 |
Why?
|
| Bioethical Issues | 1 | 2020 | 119 | 0.620 |
Why?
|
| Blood Flow Velocity | 4 | 2019 | 1381 | 0.610 |
Why?
|
| Carbon Dioxide | 7 | 2020 | 1137 | 0.600 |
Why?
|
| Fluid Therapy | 9 | 2020 | 584 | 0.600 |
Why?
|
| Polyneuropathies | 1 | 2019 | 139 | 0.590 |
Why?
|
| Barbiturates | 4 | 2019 | 113 | 0.590 |
Why?
|
| Patient Selection | 6 | 2019 | 4255 | 0.580 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2020 | 239 | 0.580 |
Why?
|
| Decompressive Craniectomy | 4 | 2020 | 76 | 0.580 |
Why?
|
| Hyperoxia | 1 | 2020 | 260 | 0.580 |
Why?
|
| Research Report | 1 | 2021 | 367 | 0.570 |
Why?
|
| S100 Proteins | 2 | 2009 | 217 | 0.560 |
Why?
|
| Somatotrophs | 1 | 2017 | 2 | 0.560 |
Why?
|
| Bronchiolitis, Viral | 2 | 2008 | 82 | 0.550 |
Why?
|
| Oxygen | 10 | 2020 | 4241 | 0.540 |
Why?
|
| Trauma Severity Indices | 3 | 2014 | 479 | 0.540 |
Why?
|
| Cerebral Veins | 1 | 2018 | 157 | 0.540 |
Why?
|
| Hypopituitarism | 3 | 2007 | 254 | 0.540 |
Why?
|
| Consciousness Disorders | 2 | 2020 | 445 | 0.540 |
Why?
|
| Erythrocyte Transfusion | 2 | 2018 | 568 | 0.530 |
Why?
|
| Drowning | 1 | 2016 | 27 | 0.530 |
Why?
|
| Off-Label Use | 1 | 2018 | 185 | 0.530 |
Why?
|
| Glucose Clamp Technique | 1 | 2017 | 262 | 0.520 |
Why?
|
| Practice Guidelines as Topic | 17 | 2020 | 7425 | 0.520 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2017 | 170 | 0.520 |
Why?
|
| Headache Disorders | 1 | 2018 | 152 | 0.510 |
Why?
|
| Intensive Care, Neonatal | 6 | 2018 | 200 | 0.510 |
Why?
|
| Diazepam | 3 | 2023 | 215 | 0.510 |
Why?
|
| Male | 125 | 2024 | 363698 | 0.500 |
Why?
|
| Neuroprotective Agents | 3 | 2016 | 959 | 0.500 |
Why?
|
| Ischemic Attack, Transient | 3 | 2015 | 870 | 0.480 |
Why?
|
| Neurosecretory Systems | 2 | 2008 | 222 | 0.480 |
Why?
|
| Nerve Growth Factors | 2 | 2009 | 565 | 0.480 |
Why?
|
| Head | 3 | 2017 | 925 | 0.470 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2015 | 175 | 0.470 |
Why?
|
| Bronchiolitis | 3 | 2013 | 493 | 0.460 |
Why?
|
| Female | 118 | 2024 | 396112 | 0.460 |
Why?
|
| Cerebral Cortex | 6 | 2021 | 5767 | 0.450 |
Why?
|
| Sodium Chloride | 3 | 2013 | 576 | 0.450 |
Why?
|
| Disclosure | 1 | 2020 | 756 | 0.450 |
Why?
|
| Homeostasis | 5 | 2019 | 3336 | 0.450 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 718 | 0.450 |
Why?
|
| Movement Disorders | 2 | 2017 | 461 | 0.440 |
Why?
|
| Informed Consent | 2 | 2017 | 1010 | 0.440 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2015 | 345 | 0.440 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 61 | 0.440 |
Why?
|
| Neurosurgery | 2 | 2019 | 683 | 0.430 |
Why?
|
| England | 11 | 2014 | 533 | 0.430 |
Why?
|
| Intubation, Intratracheal | 5 | 2013 | 1303 | 0.430 |
Why?
|
| Mannitol | 1 | 2014 | 176 | 0.430 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2014 | 116 | 0.430 |
Why?
|
| Hypoglycemic Agents | 6 | 2017 | 3110 | 0.430 |
Why?
|
| Patient Positioning | 1 | 2016 | 328 | 0.420 |
Why?
|
| Hemodynamics | 8 | 2020 | 4184 | 0.420 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 308 | 0.420 |
Why?
|
| Insulin | 9 | 2017 | 6599 | 0.420 |
Why?
|
| Child Development | 2 | 2016 | 2327 | 0.420 |
Why?
|
| Tissue and Organ Procurement | 2 | 2020 | 989 | 0.410 |
Why?
|
| Anastomosis, Surgical | 2 | 2015 | 990 | 0.410 |
Why?
|
| Brain Damage, Chronic | 3 | 2005 | 265 | 0.410 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2013 | 59 | 0.410 |
Why?
|
| Intensive Care Units | 11 | 2022 | 3800 | 0.410 |
Why?
|
| Hydrodynamics | 1 | 2013 | 163 | 0.400 |
Why?
|
| Drug Utilization | 1 | 2018 | 1187 | 0.400 |
Why?
|
| Bayes Theorem | 3 | 2019 | 2354 | 0.400 |
Why?
|
| Brain Ischemia | 7 | 2015 | 3000 | 0.400 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2017 | 624 | 0.400 |
Why?
|
| Cerebral Infarction | 1 | 2017 | 970 | 0.390 |
Why?
|
| Moyamoya Disease | 1 | 2015 | 273 | 0.390 |
Why?
|
| Glycemic Index | 3 | 2011 | 400 | 0.390 |
Why?
|
| Patient Discharge | 3 | 2019 | 3461 | 0.390 |
Why?
|
| Autonomic Nervous System | 1 | 2017 | 706 | 0.390 |
Why?
|
| Coronary Care Units | 1 | 2013 | 235 | 0.390 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2009 | 127 | 0.380 |
Why?
|
| Health Status Indicators | 1 | 2017 | 966 | 0.380 |
Why?
|
| Infusions, Intravenous | 7 | 2020 | 2229 | 0.380 |
Why?
|
| Anesthetics, Intravenous | 1 | 2014 | 397 | 0.370 |
Why?
|
| Stroke | 5 | 2020 | 9747 | 0.370 |
Why?
|
| Attitude | 1 | 2016 | 770 | 0.360 |
Why?
|
| Hypovolemia | 3 | 2006 | 47 | 0.360 |
Why?
|
| Models, Biological | 4 | 2018 | 9443 | 0.360 |
Why?
|
| Neuromuscular Diseases | 1 | 2013 | 261 | 0.360 |
Why?
|
| Vasoconstrictor Agents | 5 | 2020 | 655 | 0.350 |
Why?
|
| Blood Pressure | 9 | 2019 | 8532 | 0.350 |
Why?
|
| Influenza A Virus, H1N2 Subtype | 1 | 2010 | 4 | 0.350 |
Why?
|
| Body Temperature | 1 | 2013 | 779 | 0.350 |
Why?
|
| Neuroimmunomodulation | 3 | 2018 | 186 | 0.350 |
Why?
|
| Croup | 2 | 2003 | 22 | 0.350 |
Why?
|
| Severity of Illness Index | 15 | 2024 | 15880 | 0.350 |
Why?
|
| Hypotension | 3 | 2014 | 885 | 0.350 |
Why?
|
| Organ Transplantation | 1 | 2020 | 1174 | 0.340 |
Why?
|
| Nitric Oxide | 9 | 2002 | 2143 | 0.340 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 1167 | 0.330 |
Why?
|
| Perfusion | 1 | 2014 | 1407 | 0.320 |
Why?
|
| Trauma, Nervous System | 1 | 2009 | 35 | 0.320 |
Why?
|
| Mountaineering | 1 | 2009 | 45 | 0.320 |
Why?
|
| Enteral Nutrition | 3 | 2021 | 803 | 0.310 |
Why?
|
| Epilepsy | 3 | 2021 | 3320 | 0.310 |
Why?
|
| Prosencephalon | 1 | 2010 | 305 | 0.300 |
Why?
|
| Resuscitation | 4 | 2020 | 679 | 0.300 |
Why?
|
| Randomized Controlled Trials as Topic | 9 | 2022 | 10383 | 0.300 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1892 | 0.300 |
Why?
|
| Infant, Premature | 3 | 2016 | 2122 | 0.300 |
Why?
|
| Hyperventilation | 3 | 2005 | 78 | 0.300 |
Why?
|
| Cognition Disorders | 3 | 2012 | 3967 | 0.290 |
Why?
|
| Oxyhemoglobins | 1 | 2009 | 213 | 0.290 |
Why?
|
| Prospective Studies | 34 | 2021 | 54802 | 0.290 |
Why?
|
| Altitude | 1 | 2009 | 162 | 0.290 |
Why?
|
| Posture | 1 | 2012 | 954 | 0.280 |
Why?
|
| Corpus Callosum | 2 | 2022 | 751 | 0.280 |
Why?
|
| Intelligence | 1 | 2012 | 923 | 0.280 |
Why?
|
| Monitoring, Intraoperative | 1 | 2014 | 936 | 0.280 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 3 | 2016 | 340 | 0.280 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2011 | 485 | 0.280 |
Why?
|
| Meningitis, Meningococcal | 1 | 2007 | 43 | 0.280 |
Why?
|
| Hippocampus | 7 | 2006 | 3775 | 0.280 |
Why?
|
| Biomedical Research | 3 | 2020 | 3458 | 0.280 |
Why?
|
| Patient Transfer | 4 | 2010 | 790 | 0.270 |
Why?
|
| Models, Statistical | 3 | 2017 | 5089 | 0.270 |
Why?
|
| Positive-Pressure Respiration | 4 | 1999 | 711 | 0.270 |
Why?
|
| Hospitals | 2 | 2020 | 3888 | 0.260 |
Why?
|
| Retrospective Studies | 37 | 2024 | 81514 | 0.260 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1402 | 0.260 |
Why?
|
| Pneumonia, Ventilator-Associated | 2 | 2008 | 279 | 0.260 |
Why?
|
| Perioperative Care | 1 | 2014 | 1055 | 0.250 |
Why?
|
| Pulmonary Gas Exchange | 5 | 2014 | 389 | 0.250 |
Why?
|
| Retinal Hemorrhage | 2 | 2004 | 98 | 0.250 |
Why?
|
| Encephalocele | 2 | 2020 | 135 | 0.250 |
Why?
|
| Hypothalamic Diseases | 1 | 2007 | 132 | 0.250 |
Why?
|
| Energy Metabolism | 5 | 2014 | 2892 | 0.250 |
Why?
|
| Diffuse Axonal Injury | 1 | 2006 | 49 | 0.250 |
Why?
|
| Migraine Disorders | 1 | 2018 | 1732 | 0.250 |
Why?
|
| Acrocephalosyndactylia | 2 | 2021 | 92 | 0.250 |
Why?
|
| Hematoma, Subdural | 2 | 2004 | 128 | 0.250 |
Why?
|
| Child Mortality | 2 | 2014 | 204 | 0.240 |
Why?
|
| Lymphopenia | 2 | 2004 | 297 | 0.240 |
Why?
|
| Ambulances | 1 | 2005 | 94 | 0.240 |
Why?
|
| Adrenal Insufficiency | 1 | 2007 | 194 | 0.240 |
Why?
|
| Continuous Positive Airway Pressure | 2 | 2021 | 581 | 0.240 |
Why?
|
| Ferritins | 1 | 2007 | 600 | 0.240 |
Why?
|
| Death | 3 | 2020 | 686 | 0.230 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 3925 | 0.230 |
Why?
|
| Length of Stay | 9 | 2020 | 6485 | 0.230 |
Why?
|
| Polysomnography | 5 | 2024 | 1859 | 0.230 |
Why?
|
| Encephalitis | 2 | 2018 | 441 | 0.230 |
Why?
|
| Parainfluenza Virus 2, Human | 1 | 2003 | 8 | 0.220 |
Why?
|
| Phenotype | 3 | 2022 | 16721 | 0.220 |
Why?
|
| Persistent Fetal Circulation Syndrome | 3 | 1999 | 80 | 0.220 |
Why?
|
| Anesthesiology | 1 | 2014 | 1135 | 0.220 |
Why?
|
| Pulmonary Medicine | 1 | 2006 | 222 | 0.220 |
Why?
|
| Growth Hormone | 1 | 2005 | 566 | 0.210 |
Why?
|
| Battered Child Syndrome | 1 | 2003 | 11 | 0.210 |
Why?
|
| Guidelines as Topic | 2 | 2020 | 1394 | 0.210 |
Why?
|
| Hemostasis | 1 | 2006 | 467 | 0.210 |
Why?
|
| Wales | 4 | 2010 | 87 | 0.210 |
Why?
|
| Acute Disease | 11 | 2017 | 7232 | 0.210 |
Why?
|
| Hemoglobins | 1 | 2009 | 1530 | 0.210 |
Why?
|
| Pneumonia, Pneumocystis | 2 | 1995 | 239 | 0.210 |
Why?
|
| Isotonic Solutions | 4 | 2006 | 121 | 0.210 |
Why?
|
| Treatment Outcome | 27 | 2021 | 65188 | 0.210 |
Why?
|
| Evidence-Based Medicine | 7 | 2022 | 3685 | 0.200 |
Why?
|
| Guillain-Barre Syndrome | 1 | 2004 | 128 | 0.200 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2024 | 1896 | 0.200 |
Why?
|
| Skull | 2 | 2005 | 811 | 0.200 |
Why?
|
| Prolactin | 1 | 2004 | 625 | 0.200 |
Why?
|
| Hematology | 1 | 2006 | 243 | 0.200 |
Why?
|
| Athletic Injuries | 1 | 2012 | 1240 | 0.200 |
Why?
|
| Cerebrovascular Disorders | 1 | 2009 | 1470 | 0.200 |
Why?
|
| Hospitalization | 12 | 2018 | 10808 | 0.200 |
Why?
|
| Life Support Care | 2 | 2011 | 226 | 0.200 |
Why?
|
| Cohort Studies | 12 | 2021 | 41649 | 0.200 |
Why?
|
| Time Factors | 22 | 2021 | 40065 | 0.190 |
Why?
|
| History, 20th Century | 2 | 2024 | 2761 | 0.190 |
Why?
|
| Masks | 1 | 2003 | 209 | 0.180 |
Why?
|
| Peer Review | 1 | 2023 | 217 | 0.180 |
Why?
|
| Pleural Effusion, Malignant | 1 | 2002 | 109 | 0.180 |
Why?
|
| Papilledema | 2 | 2016 | 130 | 0.180 |
Why?
|
| Anesthetics, Inhalation | 2 | 2017 | 573 | 0.180 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2001 | 105 | 0.180 |
Why?
|
| Pilot Projects | 4 | 2018 | 8733 | 0.170 |
Why?
|
| Emergency Treatment | 2 | 2018 | 494 | 0.170 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 622 | 0.170 |
Why?
|
| Seizures, Febrile | 1 | 2021 | 109 | 0.170 |
Why?
|
| Recovery of Function | 1 | 2010 | 2966 | 0.170 |
Why?
|
| Research Design | 7 | 2022 | 6209 | 0.170 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2006 | 952 | 0.170 |
Why?
|
| Consensus | 5 | 2020 | 3202 | 0.170 |
Why?
|
| Respiration Disorders | 2 | 2004 | 362 | 0.170 |
Why?
|
| Statistics, Nonparametric | 5 | 2018 | 2844 | 0.160 |
Why?
|
| Withholding Treatment | 2 | 2011 | 621 | 0.160 |
Why?
|
| Hospitals, Pediatric | 6 | 2020 | 1846 | 0.160 |
Why?
|
| Albumins | 1 | 2002 | 577 | 0.160 |
Why?
|
| Dantrolene | 1 | 1998 | 26 | 0.160 |
Why?
|
| Sensitivity and Specificity | 6 | 2023 | 14652 | 0.160 |
Why?
|
| Emergency Service, Hospital | 5 | 2017 | 7875 | 0.160 |
Why?
|
| Serum Albumin | 1 | 2002 | 675 | 0.160 |
Why?
|
| Oxidative Stress | 2 | 2010 | 3141 | 0.150 |
Why?
|
| Animals, Newborn | 3 | 2016 | 2669 | 0.150 |
Why?
|
| Influenza, Human | 1 | 2010 | 1539 | 0.150 |
Why?
|
| United States | 11 | 2020 | 72903 | 0.150 |
Why?
|
| Bioethics | 1 | 2020 | 119 | 0.150 |
Why?
|
| Achondroplasia | 1 | 1998 | 28 | 0.150 |
Why?
|
| Clinical Trials Data Monitoring Committees | 1 | 2018 | 25 | 0.150 |
Why?
|
| Photoperiod | 1 | 2019 | 141 | 0.150 |
Why?
|
| Hepatic Encephalopathy | 1 | 2019 | 143 | 0.150 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2018 | 40 | 0.150 |
Why?
|
| Erythrocyte Count | 1 | 2018 | 158 | 0.150 |
Why?
|
| Catheter-Related Infections | 1 | 2011 | 279 | 0.150 |
Why?
|
| Decision Making | 4 | 2018 | 3965 | 0.150 |
Why?
|
| History, 21st Century | 1 | 2024 | 1574 | 0.150 |
Why?
|
| Acetylcholine | 1 | 2020 | 626 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2024 | 10729 | 0.150 |
Why?
|
| Sleep Apnea Syndromes | 3 | 2015 | 969 | 0.150 |
Why?
|
| Respiratory Tract Infections | 2 | 2003 | 1008 | 0.150 |
Why?
|
| Hypertonic Solutions | 3 | 2004 | 82 | 0.150 |
Why?
|
| Plasma Substitutes | 3 | 2004 | 57 | 0.150 |
Why?
|
| Cytokines | 3 | 2017 | 7421 | 0.150 |
Why?
|
| Neurotoxins | 3 | 1995 | 238 | 0.150 |
Why?
|
| Feeding Methods | 1 | 2017 | 35 | 0.150 |
Why?
|
| Rehydration Solutions | 3 | 2004 | 44 | 0.140 |
Why?
|
| Centralized Hospital Services | 1 | 1997 | 15 | 0.140 |
Why?
|
| Reperfusion | 1 | 1998 | 267 | 0.140 |
Why?
|
| Bed Occupancy | 1 | 1997 | 38 | 0.140 |
Why?
|
| Liver Failure, Acute | 1 | 2019 | 183 | 0.140 |
Why?
|
| Brain Stem | 2 | 2020 | 853 | 0.140 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 9071 | 0.140 |
Why?
|
| Emergencies | 3 | 2016 | 1223 | 0.140 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2001 | 896 | 0.140 |
Why?
|
| Moral Development | 1 | 2016 | 13 | 0.140 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2018 | 304 | 0.140 |
Why?
|
| ROC Curve | 4 | 2014 | 3620 | 0.140 |
Why?
|
| Parents | 2 | 2014 | 3592 | 0.140 |
Why?
|
| Postoperative Complications | 7 | 2014 | 15747 | 0.140 |
Why?
|
| Inflammation | 1 | 2017 | 10850 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 235 | 0.140 |
Why?
|
| Staphylococcal Infections | 1 | 2005 | 1393 | 0.130 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1998 | 429 | 0.130 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 1880 | 0.130 |
Why?
|
| Meningitis | 1 | 1998 | 216 | 0.130 |
Why?
|
| Leptin | 1 | 2004 | 1596 | 0.130 |
Why?
|
| Parenteral Nutrition | 2 | 2018 | 660 | 0.130 |
Why?
|
| Prognosis | 14 | 2022 | 29922 | 0.130 |
Why?
|
| Muscle Weakness | 1 | 2019 | 413 | 0.130 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 125 | 0.130 |
Why?
|
| Young Adult | 12 | 2021 | 59889 | 0.130 |
Why?
|
| Intracranial Hemorrhages | 2 | 2017 | 814 | 0.130 |
Why?
|
| Dizocilpine Maleate | 2 | 1994 | 171 | 0.130 |
Why?
|
| Immune System Diseases | 1 | 2018 | 251 | 0.130 |
Why?
|
| Snoring | 1 | 2017 | 211 | 0.130 |
Why?
|
| Myasthenia Gravis | 1 | 1998 | 214 | 0.120 |
Why?
|
| Speech Disorders | 1 | 2016 | 178 | 0.120 |
Why?
|
| Supine Position | 1 | 2016 | 209 | 0.120 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 416 | 0.120 |
Why?
|
| 1,2-Dipalmitoylphosphatidylcholine | 1 | 1995 | 40 | 0.120 |
Why?
|
| Lung | 5 | 2016 | 10033 | 0.120 |
Why?
|
| Language Development Disorders | 1 | 2016 | 194 | 0.120 |
Why?
|
| Medical Futility | 1 | 1996 | 136 | 0.120 |
Why?
|
| Altitude Sickness | 1 | 2016 | 93 | 0.120 |
Why?
|
| Lidocaine | 1 | 2018 | 550 | 0.120 |
Why?
|
| Meconium Aspiration Syndrome | 1 | 1995 | 30 | 0.120 |
Why?
|
| Tetrodotoxin | 2 | 1994 | 244 | 0.120 |
Why?
|
| Acute Kidney Injury | 3 | 2006 | 1946 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2012 | 20659 | 0.120 |
Why?
|
| Palliative Care | 2 | 2010 | 3645 | 0.120 |
Why?
|
| Pertussis Vaccine | 1 | 1994 | 39 | 0.120 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2017 | 416 | 0.120 |
Why?
|
| Internationality | 1 | 2020 | 1007 | 0.120 |
Why?
|
| Neurons | 4 | 2012 | 9525 | 0.120 |
Why?
|
| Review Literature as Topic | 1 | 2016 | 297 | 0.120 |
Why?
|
| Adult | 21 | 2023 | 223044 | 0.120 |
Why?
|
| Carbon Monoxide | 1 | 1998 | 560 | 0.120 |
Why?
|
| Comprehension | 1 | 2020 | 638 | 0.120 |
Why?
|
| Clinical Trials as Topic | 3 | 2018 | 8041 | 0.110 |
Why?
|
| Iatrogenic Disease | 1 | 2018 | 553 | 0.110 |
Why?
|
| Abdomen | 1 | 2020 | 1134 | 0.110 |
Why?
|
| Brazil | 2 | 2011 | 1248 | 0.110 |
Why?
|
| Cell Enlargement | 1 | 2014 | 58 | 0.110 |
Why?
|
| Methylprednisolone | 1 | 1996 | 386 | 0.110 |
Why?
|
| Bereavement | 2 | 2018 | 308 | 0.110 |
Why?
|
| Pulmonary Surfactants | 1 | 1995 | 169 | 0.110 |
Why?
|
| Follow-Up Studies | 10 | 2023 | 39193 | 0.110 |
Why?
|
| Logistic Models | 4 | 2008 | 13266 | 0.110 |
Why?
|
| Neuroblastoma | 1 | 2002 | 1263 | 0.110 |
Why?
|
| Risk Factors | 11 | 2020 | 74840 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2005 | 2477 | 0.110 |
Why?
|
| Hypercapnia | 1 | 1995 | 259 | 0.110 |
Why?
|
| Emergency Medical Services | 2 | 2020 | 1938 | 0.110 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 1997 | 329 | 0.100 |
Why?
|
| Immunization, Secondary | 2 | 1999 | 373 | 0.100 |
Why?
|
| Syndrome | 5 | 2020 | 3271 | 0.100 |
Why?
|
| Severe Acute Respiratory Syndrome | 2 | 2004 | 136 | 0.100 |
Why?
|
| Bronchi | 1 | 1997 | 843 | 0.100 |
Why?
|
| Receptors, Amino Acid | 1 | 1992 | 30 | 0.100 |
Why?
|
| Feedback | 1 | 2017 | 796 | 0.100 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2018 | 790 | 0.100 |
Why?
|
| Injections, Intramuscular | 1 | 2014 | 552 | 0.100 |
Why?
|
| International Classification of Diseases | 1 | 2018 | 935 | 0.100 |
Why?
|
| India | 1 | 2019 | 2334 | 0.100 |
Why?
|
| Education, Medical, Graduate | 2 | 2006 | 2418 | 0.100 |
Why?
|
| Neurologic Examination | 3 | 2023 | 912 | 0.100 |
Why?
|
| Health Care Costs | 3 | 2014 | 3242 | 0.100 |
Why?
|
| Hernia, Umbilical | 1 | 1993 | 102 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2020 | 12056 | 0.100 |
Why?
|
| Tomography, Optical Coherence | 2 | 2023 | 2932 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2019 | 20124 | 0.100 |
Why?
|
| Medical Errors | 1 | 2000 | 1260 | 0.100 |
Why?
|
| Laryngeal Neoplasms | 1 | 1996 | 512 | 0.100 |
Why?
|
| Injections, Intravenous | 1 | 2014 | 1377 | 0.100 |
Why?
|
| Trachea | 2 | 1997 | 1085 | 0.100 |
Why?
|
| Human Growth Hormone | 1 | 2017 | 638 | 0.100 |
Why?
|
| Guideline Adherence | 2 | 2020 | 2243 | 0.090 |
Why?
|
| Conscious Sedation | 1 | 2016 | 531 | 0.090 |
Why?
|
| Analgesia | 1 | 2016 | 461 | 0.090 |
Why?
|
| Neonatology | 1 | 2013 | 142 | 0.090 |
Why?
|
| Isoflurane | 1 | 2014 | 384 | 0.090 |
Why?
|
| Erythropoietin | 1 | 2016 | 716 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 36532 | 0.090 |
Why?
|
| Administration, Inhalation | 7 | 2002 | 1154 | 0.090 |
Why?
|
| Analysis of Variance | 6 | 2017 | 6203 | 0.090 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 1991 | 37 | 0.090 |
Why?
|
| Nausea | 1 | 2014 | 680 | 0.090 |
Why?
|
| Data Collection | 1 | 2020 | 3318 | 0.090 |
Why?
|
| Hemangioma | 1 | 1996 | 723 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2014 | 768 | 0.090 |
Why?
|
| Ventilator Weaning | 3 | 2010 | 170 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2017 | 2108 | 0.090 |
Why?
|
| Quality of Life | 4 | 2022 | 13462 | 0.090 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2010 | 74 | 0.080 |
Why?
|
| Thiopental | 1 | 1989 | 55 | 0.080 |
Why?
|
| Diagnosis, Differential | 4 | 2017 | 12976 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2011 | 2424 | 0.080 |
Why?
|
| Rats | 8 | 2016 | 23707 | 0.080 |
Why?
|
| Pain | 1 | 2004 | 5077 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2017 | 1936 | 0.080 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2014 | 855 | 0.080 |
Why?
|
| Anemia | 1 | 2018 | 1511 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2007 | 6322 | 0.080 |
Why?
|
| Ketamine | 1 | 2014 | 525 | 0.080 |
Why?
|
| Drug Design | 1 | 2013 | 1042 | 0.080 |
Why?
|
| Argentina | 1 | 2009 | 249 | 0.080 |
Why?
|
| Pituitary Gland | 2 | 2008 | 631 | 0.080 |
Why?
|
| Catheters, Indwelling | 1 | 1991 | 438 | 0.080 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2009 | 282 | 0.070 |
Why?
|
| Analgesics, Opioid | 1 | 2004 | 3835 | 0.070 |
Why?
|
| Culture Techniques | 3 | 2001 | 515 | 0.070 |
Why?
|
| Analgesics | 1 | 2014 | 1060 | 0.070 |
Why?
|
| Craniofacial Dysostosis | 1 | 2008 | 74 | 0.070 |
Why?
|
| Complementary Therapies | 1 | 2011 | 487 | 0.070 |
Why?
|
| Spasms, Infantile | 1 | 1991 | 302 | 0.070 |
Why?
|
| Blood-Brain Barrier | 1 | 2014 | 1037 | 0.070 |
Why?
|
| Aging | 2 | 2004 | 8731 | 0.070 |
Why?
|
| Disease Progression | 1 | 2024 | 13632 | 0.070 |
Why?
|
| Sleep Stages | 2 | 2024 | 698 | 0.070 |
Why?
|
| Phosphocreatine | 2 | 2000 | 258 | 0.070 |
Why?
|
| Bronchodilator Agents | 2 | 2002 | 514 | 0.070 |
Why?
|
| Respiratory System Agents | 2 | 1997 | 30 | 0.070 |
Why?
|
| Radiography | 2 | 2014 | 6919 | 0.070 |
Why?
|
| Europe | 4 | 2013 | 3423 | 0.070 |
Why?
|
| Risk Adjustment | 1 | 2010 | 596 | 0.070 |
Why?
|
| Acute Lung Injury | 1 | 2010 | 377 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 597 | 0.070 |
Why?
|
| Thrombolytic Therapy | 1 | 2015 | 2059 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2024 | 4873 | 0.070 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2006 | 20 | 0.070 |
Why?
|
| Shaken Baby Syndrome | 2 | 2004 | 24 | 0.070 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 4850 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6309 | 0.070 |
Why?
|
| Whooping Cough | 2 | 1999 | 87 | 0.070 |
Why?
|
| Diffusion Tensor Imaging | 2 | 2022 | 2410 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 1996 | 2132 | 0.070 |
Why?
|
| Patient Admission | 2 | 2015 | 1365 | 0.070 |
Why?
|
| Astrocytes | 1 | 2014 | 1345 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2014 | 1456 | 0.070 |
Why?
|
| Bicarbonates | 2 | 2005 | 293 | 0.060 |
Why?
|
| Poverty Areas | 3 | 2018 | 268 | 0.060 |
Why?
|
| Diagnosis-Related Groups | 2 | 1998 | 445 | 0.060 |
Why?
|
| Hyponatremia | 1 | 2009 | 276 | 0.060 |
Why?
|
| Microcirculation | 1 | 2011 | 1280 | 0.060 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 2080 | 0.060 |
Why?
|
| Heart Rate | 1 | 2017 | 4204 | 0.060 |
Why?
|
| State Medicine | 1 | 2007 | 219 | 0.060 |
Why?
|
| Cerebral Arteries | 1 | 1988 | 490 | 0.060 |
Why?
|
| Ireland | 3 | 2015 | 170 | 0.060 |
Why?
|
| Transportation of Patients | 2 | 2018 | 178 | 0.060 |
Why?
|
| Child Behavior | 1 | 2011 | 865 | 0.060 |
Why?
|
| Behavior Therapy | 1 | 2011 | 884 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2017 | 6404 | 0.060 |
Why?
|
| Burnout, Professional | 1 | 2014 | 711 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1995 | 1560 | 0.060 |
Why?
|
| Oximetry | 1 | 2009 | 459 | 0.060 |
Why?
|
| Hospitals, University | 1 | 2007 | 574 | 0.060 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 1941 | 0.060 |
Why?
|
| Societies, Medical | 3 | 2023 | 3956 | 0.060 |
Why?
|
| Reference Standards | 1 | 2009 | 1013 | 0.060 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2009 | 361 | 0.060 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2007 | 616 | 0.060 |
Why?
|
| Patient Care Team | 4 | 2011 | 2517 | 0.060 |
Why?
|
| Point-of-Care Systems | 1 | 2014 | 1217 | 0.060 |
Why?
|
| Brain Hemorrhage, Traumatic | 1 | 2004 | 18 | 0.060 |
Why?
|
| Adrenal Gland Diseases | 1 | 2005 | 141 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 3607 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2005 | 180 | 0.060 |
Why?
|
| Risk | 2 | 2007 | 9591 | 0.060 |
Why?
|
| Social Support | 1 | 2014 | 2192 | 0.060 |
Why?
|
| Sleep | 2 | 2017 | 4813 | 0.060 |
Why?
|
| Medical History Taking | 2 | 2006 | 777 | 0.050 |
Why?
|
| N-Methylaspartate | 3 | 1995 | 228 | 0.050 |
Why?
|
| Diffusion | 1 | 2005 | 808 | 0.050 |
Why?
|
| Hormones | 1 | 2007 | 863 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3100 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3223 | 0.050 |
Why?
|
| Heart | 1 | 2016 | 4414 | 0.050 |
Why?
|
| Osmolar Concentration | 2 | 2002 | 655 | 0.050 |
Why?
|
| Kenya | 2 | 2018 | 758 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 1993 | 1604 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2007 | 1187 | 0.050 |
Why?
|
| Cross Infection | 2 | 2004 | 1427 | 0.050 |
Why?
|
| Colloids | 1 | 2002 | 122 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2007 | 753 | 0.050 |
Why?
|
| Airway Obstruction | 2 | 1998 | 665 | 0.050 |
Why?
|
| Hemorrhage | 2 | 2005 | 3461 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 1308 | 0.050 |
Why?
|
| Spinal Puncture | 1 | 2004 | 284 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2000 | 1999 | 0.050 |
Why?
|
| Radiation Dosage | 2 | 2012 | 1944 | 0.050 |
Why?
|
| Long-Term Care | 1 | 2006 | 629 | 0.050 |
Why?
|
| Professional-Family Relations | 1 | 2005 | 501 | 0.050 |
Why?
|
| Medical Audit | 3 | 2009 | 452 | 0.050 |
Why?
|
| Cheyne-Stokes Respiration | 1 | 2021 | 38 | 0.050 |
Why?
|
| Plastics | 1 | 2022 | 117 | 0.050 |
Why?
|
| Nerve Degeneration | 1 | 2006 | 748 | 0.050 |
Why?
|
| Diuretics, Osmotic | 1 | 2001 | 32 | 0.050 |
Why?
|
| Equipment Failure | 1 | 2003 | 578 | 0.050 |
Why?
|
| Survival Rate | 5 | 2005 | 12795 | 0.050 |
Why?
|
| Databases, Factual | 2 | 2021 | 8067 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 5526 | 0.040 |
Why?
|
| Dura Mater | 1 | 2003 | 296 | 0.040 |
Why?
|
| Glutamates | 2 | 1992 | 384 | 0.040 |
Why?
|
| Atrophy | 1 | 2006 | 1635 | 0.040 |
Why?
|
| Energy Intake | 2 | 2021 | 2141 | 0.040 |
Why?
|
| Research | 2 | 2006 | 1975 | 0.040 |
Why?
|
| France | 1 | 2011 | 495 | 0.040 |
Why?
|
| Iron | 1 | 2009 | 1816 | 0.040 |
Why?
|
| Peer Review, Research | 1 | 2023 | 341 | 0.040 |
Why?
|
| Syringomyelia | 1 | 2020 | 66 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2011 | 5302 | 0.040 |
Why?
|
| Phenytoin | 1 | 2020 | 189 | 0.040 |
Why?
|
| Cognition | 1 | 2017 | 7049 | 0.040 |
Why?
|
| Phenobarbital | 1 | 2020 | 192 | 0.040 |
Why?
|
| Cadaver | 2 | 2022 | 1359 | 0.040 |
Why?
|
| Catheterization, Central Venous | 1 | 2004 | 539 | 0.040 |
Why?
|
| Glutamic Acid | 3 | 1995 | 1180 | 0.040 |
Why?
|
| Hospice Care | 2 | 2010 | 678 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2003 | 705 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2023 | 22223 | 0.040 |
Why?
|
| Intracellular Membranes | 1 | 2000 | 386 | 0.040 |
Why?
|
| Epilepsy, Generalized | 1 | 2021 | 183 | 0.040 |
Why?
|
| Pyridostigmine Bromide | 1 | 1998 | 32 | 0.040 |
Why?
|
| Algorithms | 5 | 2020 | 14071 | 0.040 |
Why?
|
| Anisotropy | 1 | 2022 | 1282 | 0.040 |
Why?
|
| Pulmonary Heart Disease | 1 | 1998 | 33 | 0.040 |
Why?
|
| Adenoids | 1 | 1998 | 35 | 0.040 |
Why?
|
| Trauma Centers | 1 | 2004 | 952 | 0.040 |
Why?
|
| Acidosis, Respiratory | 1 | 1998 | 37 | 0.040 |
Why?
|
| Viscera | 1 | 1999 | 137 | 0.040 |
Why?
|
| Optic Nerve | 1 | 2022 | 567 | 0.040 |
Why?
|
| DNA Fragmentation | 1 | 1998 | 238 | 0.040 |
Why?
|
| Ion Transport | 1 | 1999 | 322 | 0.040 |
Why?
|
| Prevalence | 4 | 2020 | 15842 | 0.040 |
Why?
|
| Edema | 1 | 2002 | 760 | 0.040 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2000 | 3672 | 0.040 |
Why?
|
| Convalescence | 1 | 1998 | 107 | 0.040 |
Why?
|
| Apoptosis | 2 | 2004 | 9514 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 1998 | 193 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2005 | 1424 | 0.040 |
Why?
|
| Mentors | 1 | 2023 | 671 | 0.040 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2010 | 3356 | 0.040 |
Why?
|
| Victoria | 1 | 1997 | 64 | 0.040 |
Why?
|
| Physical Examination | 1 | 2004 | 1266 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2022 | 2798 | 0.040 |
Why?
|
| Scotland | 1 | 1997 | 115 | 0.040 |
Why?
|
| Peer Group | 1 | 2023 | 701 | 0.040 |
Why?
|
| Clinical Competence | 2 | 2005 | 4863 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2015 | 2263 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 4348 | 0.030 |
Why?
|
| Respiration | 2 | 2021 | 1653 | 0.030 |
Why?
|
| Ghana | 1 | 2018 | 333 | 0.030 |
Why?
|
| Age Factors | 4 | 2020 | 18380 | 0.030 |
Why?
|
| Hyperemia | 1 | 1998 | 224 | 0.030 |
Why?
|
| Immunization | 1 | 2001 | 1219 | 0.030 |
Why?
|
| Meningococcal Infections | 1 | 1997 | 78 | 0.030 |
Why?
|
| Age Distribution | 2 | 2015 | 2858 | 0.030 |
Why?
|
| ABO Blood-Group System | 1 | 1999 | 380 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 7123 | 0.030 |
Why?
|
| Physicians | 1 | 2014 | 4588 | 0.030 |
Why?
|
| Animals | 12 | 2018 | 168764 | 0.030 |
Why?
|
| Hypertrophy | 1 | 1998 | 559 | 0.030 |
Why?
|
| London | 1 | 1996 | 233 | 0.030 |
Why?
|
| Incidence | 3 | 2015 | 21480 | 0.030 |
Why?
|
| Sex Factors | 2 | 2020 | 10603 | 0.030 |
Why?
|
| Globus Pallidus | 1 | 1997 | 248 | 0.030 |
Why?
|
| Ethiopia | 1 | 2018 | 485 | 0.030 |
Why?
|
| Immunization Programs | 1 | 1999 | 267 | 0.030 |
Why?
|
| Aortic Valve | 1 | 1986 | 1968 | 0.030 |
Why?
|
| Child Behavior Disorders | 1 | 2001 | 814 | 0.030 |
Why?
|
| Epoetin Alfa | 1 | 2016 | 78 | 0.030 |
Why?
|
| Isotope Labeling | 1 | 1997 | 389 | 0.030 |
Why?
|
| Rett Syndrome | 1 | 1997 | 163 | 0.030 |
Why?
|
| Rwanda | 1 | 2018 | 672 | 0.030 |
Why?
|
| Receptors, Erythropoietin | 1 | 2016 | 145 | 0.030 |
Why?
|
| Orofaciodigital Syndromes | 1 | 1995 | 21 | 0.030 |
Why?
|
| Child Abuse | 1 | 2004 | 1090 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2005 | 3222 | 0.030 |
Why?
|
| Taurine | 1 | 1996 | 91 | 0.030 |
Why?
|
| Health Surveys | 2 | 2013 | 4056 | 0.030 |
Why?
|
| Cerebral Palsy | 1 | 2020 | 481 | 0.030 |
Why?
|
| Deoxyglucose | 2 | 1994 | 321 | 0.030 |
Why?
|
| Risk Assessment | 5 | 2015 | 24282 | 0.030 |
Why?
|
| Calpain | 1 | 2016 | 145 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 1998 | 412 | 0.030 |
Why?
|
| Oxygen Consumption | 2 | 1999 | 1870 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2001 | 1668 | 0.030 |
Why?
|
| Linear Models | 1 | 2005 | 5876 | 0.030 |
Why?
|
| Hyperplasia | 1 | 1998 | 1144 | 0.030 |
Why?
|
| Diseases in Twins | 1 | 1997 | 448 | 0.030 |
Why?
|
| Ventilators, Mechanical | 1 | 1997 | 291 | 0.030 |
Why?
|
| Receptors, Kainic Acid | 1 | 1995 | 91 | 0.030 |
Why?
|
| Hospitals, Public | 1 | 1996 | 203 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2022 | 5993 | 0.030 |
Why?
|
| Respiratory System | 1 | 1998 | 559 | 0.030 |
Why?
|
| Depersonalization | 1 | 2014 | 40 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1998 | 1752 | 0.030 |
Why?
|
| Nitroglycerin | 1 | 1996 | 331 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2020 | 1137 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2017 | 993 | 0.030 |
Why?
|
| Infant, Small for Gestational Age | 1 | 1997 | 469 | 0.030 |
Why?
|
| Referral and Consultation | 2 | 2013 | 3615 | 0.030 |
Why?
|
| Treatment Failure | 2 | 1999 | 2652 | 0.030 |
Why?
|
| Glucose | 2 | 1998 | 4335 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 564 | 0.030 |
Why?
|
| Mathematical Concepts | 1 | 2014 | 77 | 0.030 |
Why?
|
| Tracheal Stenosis | 1 | 1996 | 227 | 0.030 |
Why?
|
| Cephalometry | 1 | 2015 | 380 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1603 | 0.030 |
Why?
|
| Home Care Services | 1 | 2010 | 660 | 0.030 |
Why?
|
| Calorimetry, Indirect | 1 | 2014 | 176 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1995 | 334 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 1999 | 750 | 0.030 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2016 | 246 | 0.030 |
Why?
|
| Disease Transmission, Infectious | 2 | 1999 | 560 | 0.030 |
Why?
|
| Symporters | 1 | 2016 | 362 | 0.030 |
Why?
|
| Esophageal Atresia | 1 | 1996 | 225 | 0.030 |
Why?
|
| Achievement | 1 | 2014 | 287 | 0.030 |
Why?
|
| Benzamides | 1 | 1998 | 1377 | 0.030 |
Why?
|
| Retina | 1 | 2023 | 2657 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 2012 | 81 | 0.020 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 714 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2020 | 986 | 0.020 |
Why?
|
| Histological Techniques | 1 | 1992 | 193 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 1995 | 551 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2018 | 1138 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1996 | 1526 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2020 | 1022 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2014 | 434 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1995 | 568 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2020 | 2020 | 0.020 |
Why?
|
| Stomach | 1 | 1996 | 699 | 0.020 |
Why?
|
| Potassium | 1 | 1996 | 1311 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2020 | 1519 | 0.020 |
Why?
|
| Synapses | 1 | 2001 | 1754 | 0.020 |
Why?
|
| Kainic Acid | 1 | 1991 | 204 | 0.020 |
Why?
|
| Blood Pressure Monitors | 1 | 1991 | 33 | 0.020 |
Why?
|
| Decompression, Surgical | 2 | 2008 | 603 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2001 | 10070 | 0.020 |
Why?
|
| Brain Mapping | 2 | 2005 | 6601 | 0.020 |
Why?
|
| Transducers, Pressure | 1 | 1991 | 52 | 0.020 |
Why?
|
| Forced Expiratory Volume | 1 | 1996 | 1828 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2014 | 1589 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2020 | 12509 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 1992 | 576 | 0.020 |
Why?
|
| Family Health | 1 | 1994 | 1253 | 0.020 |
Why?
|
| Terminal Care | 1 | 2011 | 1774 | 0.020 |
Why?
|
| Health Personnel | 1 | 2023 | 3390 | 0.020 |
Why?
|
| Cervical Vertebrae | 1 | 1995 | 974 | 0.020 |
Why?
|
| Rest | 1 | 2014 | 942 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2006 | 5508 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 1996 | 833 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2013 | 1731 | 0.020 |
Why?
|
| Partial Pressure | 2 | 1999 | 245 | 0.020 |
Why?
|
| Cerebral Ventriculography | 1 | 2008 | 44 | 0.020 |
Why?
|
| Goals | 1 | 2013 | 719 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1998 | 3715 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2010 | 9649 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 2592 | 0.020 |
Why?
|
| HIV Infections | 1 | 1994 | 17533 | 0.020 |
Why?
|
| Ophthalmoscopy | 1 | 2008 | 172 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 14751 | 0.020 |
Why?
|
| North America | 1 | 2010 | 1285 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 10261 | 0.020 |
Why?
|
| Food Additives | 1 | 1986 | 23 | 0.020 |
Why?
|
| Comorbidity | 2 | 2015 | 10563 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2008 | 527 | 0.020 |
Why?
|
| Diabetes Insipidus | 1 | 2006 | 143 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2017 | 2074 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2006 | 5946 | 0.020 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 1986 | 176 | 0.020 |
Why?
|
| Puberty, Precocious | 1 | 2006 | 163 | 0.020 |
Why?
|
| Differential Threshold | 1 | 2005 | 80 | 0.010 |
Why?
|
| Wounds and Injuries | 2 | 2010 | 2511 | 0.010 |
Why?
|
| Orbit | 1 | 2008 | 456 | 0.010 |
Why?
|
| Potassium Deficiency | 1 | 2004 | 9 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3432 | 0.010 |
Why?
|
| APACHE | 1 | 2004 | 268 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2017 | 6255 | 0.010 |
Why?
|
| Periodicity | 1 | 2005 | 345 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 1326 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2004 | 87 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 2010 | 962 | 0.010 |
Why?
|
| Nutrition Therapy | 1 | 2005 | 101 | 0.010 |
Why?
|
| Hypophosphatemia | 1 | 2004 | 92 | 0.010 |
Why?
|
| Nutrition Disorders | 1 | 2004 | 203 | 0.010 |
Why?
|
| Caspase 1 | 1 | 2004 | 227 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 1997 | 2895 | 0.010 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2004 | 195 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2014 | 3139 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 26318 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1997 | 3446 | 0.010 |
Why?
|
| Disease Management | 1 | 2013 | 2535 | 0.010 |
Why?
|
| Interleukin-18 | 1 | 2004 | 251 | 0.010 |
Why?
|
| Extracellular Fluid | 1 | 2004 | 165 | 0.010 |
Why?
|
| Emotions | 1 | 2014 | 2763 | 0.010 |
Why?
|
| Proteins | 1 | 1997 | 5995 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 851 | 0.010 |
Why?
|
| National Health Programs | 1 | 2006 | 443 | 0.010 |
Why?
|
| Vaccination | 1 | 1994 | 3426 | 0.010 |
Why?
|
| Organ Culture Techniques | 2 | 1995 | 788 | 0.010 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2005 | 269 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2004 | 790 | 0.010 |
Why?
|
| Renal Replacement Therapy | 1 | 2004 | 281 | 0.010 |
Why?
|
| Cebidae | 1 | 1981 | 21 | 0.010 |
Why?
|
| Muscle Hypertonia | 1 | 1981 | 12 | 0.010 |
Why?
|
| Survivors | 1 | 2012 | 2372 | 0.010 |
Why?
|
| Hypothalamus | 1 | 2006 | 993 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7478 | 0.010 |
Why?
|
| Coronavirus | 1 | 2003 | 155 | 0.010 |
Why?
|
| Functional Laterality | 1 | 1967 | 2243 | 0.010 |
Why?
|
| Injury Severity Score | 1 | 2004 | 1050 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8703 | 0.010 |
Why?
|
| Saimiri | 1 | 1981 | 337 | 0.010 |
Why?
|
| Craniotomy | 1 | 2005 | 730 | 0.010 |
Why?
|
| Phosphates | 1 | 2004 | 763 | 0.010 |
Why?
|
| Accidents, Traffic | 1 | 2005 | 818 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 18293 | 0.010 |
Why?
|
| Seasons | 1 | 2005 | 1524 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 8923 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2004 | 783 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2004 | 1151 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2004 | 975 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2014 | 3675 | 0.010 |
Why?
|
| Violence | 1 | 2004 | 935 | 0.010 |
Why?
|
| Walking | 1 | 2005 | 1198 | 0.010 |
Why?
|
| Alkalosis | 1 | 1997 | 55 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2004 | 1470 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 1999 | 228 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 3273 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2004 | 1087 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2004 | 1801 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1316 | 0.010 |
Why?
|
| Muscles | 1 | 1981 | 1578 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2004 | 1811 | 0.010 |
Why?
|
| Leucine | 1 | 1997 | 546 | 0.010 |
Why?
|
| Phenylalanine | 1 | 1997 | 367 | 0.010 |
Why?
|
| Quisqualic Acid | 1 | 1995 | 35 | 0.010 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 1995 | 70 | 0.010 |
Why?
|
| Amino Acid Transport System X-AG | 1 | 1995 | 38 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 4137 | 0.010 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 1999 | 328 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2008 | 7838 | 0.010 |
Why?
|
| Potassium Cyanide | 1 | 1994 | 17 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1999 | 1831 | 0.010 |
Why?
|
| Frozen Sections | 1 | 1995 | 153 | 0.010 |
Why?
|
| Glycine | 1 | 1997 | 672 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1986 | 3832 | 0.010 |
Why?
|
| Biopsy | 2 | 1996 | 6763 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 1996 | 247 | 0.010 |
Why?
|
| Motor Cortex | 1 | 1981 | 1003 | 0.010 |
Why?
|
| Pulmonary Fibrosis | 1 | 1997 | 503 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3690 | 0.010 |
Why?
|
| Echocardiography | 1 | 1986 | 5045 | 0.010 |
Why?
|
| Vital Capacity | 1 | 1996 | 995 | 0.010 |
Why?
|
| Heart Failure | 1 | 1997 | 11840 | 0.010 |
Why?
|
| Pyramidal Tracts | 1 | 1994 | 249 | 0.010 |
Why?
|
| Propidium | 1 | 1991 | 42 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1999 | 1354 | 0.010 |
Why?
|
| Age of Onset | 1 | 1999 | 3344 | 0.010 |
Why?
|
| Oxidative Phosphorylation | 1 | 1994 | 502 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 1995 | 1105 | 0.010 |
Why?
|
| Foreign Bodies | 1 | 1996 | 402 | 0.010 |
Why?
|
| Anthropometry | 1 | 1996 | 1338 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2005 | 2598 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 8529 | 0.010 |
Why?
|
| Communication | 1 | 2005 | 3916 | 0.010 |
Why?
|
| Catheterization | 1 | 1996 | 1425 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1991 | 412 | 0.010 |
Why?
|
| Deglutition Disorders | 1 | 1996 | 639 | 0.010 |
Why?
|
| Glycolysis | 1 | 1994 | 838 | 0.010 |
Why?
|
| Body Height | 1 | 1996 | 1562 | 0.010 |
Why?
|
| Cleft Palate | 1 | 1995 | 591 | 0.010 |
Why?
|
| Immunocompromised Host | 1 | 1995 | 866 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1986 | 4697 | 0.010 |
Why?
|
| Fluorescence | 1 | 1991 | 753 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1997 | 2415 | 0.000 |
Why?
|
| Delivery of Health Care | 1 | 2006 | 5370 | 0.000 |
Why?
|
| Middle Aged | 4 | 2014 | 223009 | 0.000 |
Why?
|
| Cause of Death | 1 | 1998 | 3708 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1991 | 1072 | 0.000 |
Why?
|
| Sodium Glutamate | 1 | 1986 | 22 | 0.000 |
Why?
|
| Naphthalenesulfonates | 1 | 1986 | 17 | 0.000 |
Why?
|
| Sensation | 1 | 1967 | 331 | 0.000 |
Why?
|
| Organic Chemicals | 1 | 1986 | 211 | 0.000 |
Why?
|
| Body Weight | 1 | 1996 | 4622 | 0.000 |
Why?
|
| Mouth | 1 | 1986 | 381 | 0.000 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1986 | 346 | 0.000 |
Why?
|
| Aged | 3 | 2004 | 171117 | 0.000 |
Why?
|
| Extremities | 1 | 1967 | 869 | 0.000 |
Why?
|
| Cerebral Decortication | 1 | 1981 | 11 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 1998 | 15398 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 13648 | 0.000 |
Why?
|
| Movement | 1 | 1967 | 1462 | 0.000 |
Why?
|
| Face | 1 | 1986 | 1028 | 0.000 |
Why?
|
| Meningioma | 1 | 1967 | 1221 | 0.000 |
Why?
|
| Food Hypersensitivity | 1 | 1986 | 737 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1995 | 11641 | 0.000 |
Why?
|
| Electromyography | 1 | 1981 | 1399 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1995 | 59489 | 0.000 |
Why?
|